[HTML][HTML] Vaccines and therapeutics for immunocompromised patients with COVID-19
The COVID-19 pandemic has disproportionately impacted immunocompromised patients.
This diverse group is at increased risk for impaired vaccine responses, progression to …
This diverse group is at increased risk for impaired vaccine responses, progression to …
Vaccines and therapeutics for immunocompromised patients with COVID-19
S Shoham, C Batista, YB Amor, O Ergonul… - …, 2023 - pubmed.ncbi.nlm.nih.gov
The COVID-19 pandemic has disproportionately impacted immunocompromised patients.
This diverse group is at increased risk for impaired vaccine responses, progression to …
This diverse group is at increased risk for impaired vaccine responses, progression to …
[PDF][PDF] Vaccines and therapeutics for immunocompromised patients with COVID-19
S Shoham, C Batista, YB Amor, O Ergonul… - …, 2023 - colmedicosantafe2.org.ar
The COVID-19 pandemic has disproportionately impacted immunocompromised patients.
This diverse group is at increased risk for impaired vaccine responses, progression to …
This diverse group is at increased risk for impaired vaccine responses, progression to …
Vaccines and therapeutics for immunocompromised patients with COVID-19.
S Shoham, C Batista, O Ergonul, M Hassanain… - …, 2023 - europepmc.org
The COVID-19 pandemic has disproportionately impacted immunocompromised patients.
This diverse group is at increased risk for impaired vaccine responses, progression to …
This diverse group is at increased risk for impaired vaccine responses, progression to …
Vaccines and therapeutics for immunocompromised patients with COVID-19.
S Shoham, C Batista, YB Amor, O Ergonul… - 2023 - cabidigitallibrary.org
The COVID-19 pandemic has disproportionately impacted immunocompromised patients.
This diverse group is at increased risk for impaired vaccine responses, progression to …
This diverse group is at increased risk for impaired vaccine responses, progression to …
[HTML][HTML] Vaccines and therapeutics for immunocompromised patients with COVID-19
S Shoham, C Batista, YB Amor, O Ergonul… - …, 2023 - ncbi.nlm.nih.gov
The COVID-19 pandemic has disproportionately impacted immunocompromised patients.
This diverse group is at increased risk for impaired vaccine responses, progression to …
This diverse group is at increased risk for impaired vaccine responses, progression to …
[HTML][HTML] Vaccines and therapeutics for immunocompromised patients with COVID-19
S Shoham, C Batista, YB Amor, O Ergonul… - eClinicalMedicine, 2023 - Elsevier
The COVID-19 pandemic has disproportionately impacted immunocompromised patients.
This diverse group is at increased risk for impaired vaccine responses, progression to …
This diverse group is at increased risk for impaired vaccine responses, progression to …
Vaccines and therapeutics for immunocompromised patients with COVID-19.
S Shoham, C Batista, O Ergonul, M Hassanain… - …, 2023 - europepmc.org
The COVID-19 pandemic has disproportionately impacted immunocompromised patients.
This diverse group is at increased risk for impaired vaccine responses, progression to …
This diverse group is at increased risk for impaired vaccine responses, progression to …